Pfizer Dodges More Sanctions In Neurontin Antitrust MDL

By Bibeka Shrestha · July 7, 2011, 3:44 PM EDT

A magistrate judge refused Tuesday to sanction Pfizer Inc. by striking its denial that it promoted off-label uses of epilepsy drug Neurontin, the latest in a New Jersey multidistrict litigation claiming...

To view the full article, register now.